Dogovski Con, Gorman Michael A, Ketaren Natalia E, Praszkier Judy, Zammit Leanne M, Mertens Haydyn D, Bryant Gary, Yang Ji, Griffin Michael D W, Pearce F Grant, Gerrard Juliet A, Jameson Geoffrey B, Parker Michael W, Robins-Browne Roy M, Perugini Matthew A
Department of Biochemistry, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria, Australia ; Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Victoria, Australia.
St Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia.
PLoS One. 2013 Dec 13;8(12):e83419. doi: 10.1371/journal.pone.0083419. eCollection 2013.
Given the rise in drug-resistant Streptococcus pneumoniae, there is an urgent need to discover new antimicrobials targeting this pathogen and an equally urgent need to characterize new drug targets. A promising antibiotic target is dihydrodipicolinate synthase (DHDPS), which catalyzes the rate-limiting step in lysine biosynthesis. In this study, we firstly show by gene knock out studies that S. pneumoniae (sp) lacking the DHDPS gene is unable to grow unless supplemented with lysine-rich media. We subsequently set out to characterize the structure, function and stability of the enzyme drug target. Our studies show that sp-DHDPS is folded and active with a k(cat) = 22 s(-1), K(M)(PYR) = 2.55 ± 0.05 mM and K(M)(ASA) = 0.044 ± 0.003 mM. Thermal denaturation experiments demonstrate sp-DHDPS exhibits an apparent melting temperature (T(M)(app)) of 72 °C, which is significantly greater than Escherichia coli DHDPS (Ec-DHDPS) (T(M)(app) = 59 °C). Sedimentation studies show that sp-DHDPS exists in a dimer-tetramer equilibrium with a K(D)(4→2) = 1.7 nM, which is considerably tighter than its E. coli ortholog (K(D)(4→2) = 76 nM). To further characterize the structure of the enzyme and probe its enhanced stability, we solved the high resolution (1.9 Å) crystal structure of sp-DHDPS (PDB ID 3VFL). The enzyme is tetrameric in the crystal state, consistent with biophysical measurements in solution. Although the sp-DHDPS and Ec-DHDPS active sites are almost identical, the tetramerization interface of the s. pneumoniae enzyme is significantly different in composition and has greater buried surface area (800 Å(2)) compared to its E. coli counterpart (500 Å(2)). This larger interface area is consistent with our solution studies demonstrating that sp-DHDPS is considerably more thermally and thermodynamically stable than Ec-DHDPS. Our study describe for the first time the knock-out phenotype, solution properties, stability and crystal structure of DHDPS from S. pneumoniae, a promising antimicrobial target.
鉴于耐药性肺炎链球菌的增加,迫切需要发现针对这种病原体的新型抗菌药物,同时也迫切需要鉴定新的药物靶点。一个有前景的抗生素靶点是二氢二吡啶二羧酸合酶(DHDPS),它催化赖氨酸生物合成中的限速步骤。在本研究中,我们首先通过基因敲除研究表明,缺乏DHDPS基因的肺炎链球菌(sp)除非补充富含赖氨酸的培养基,否则无法生长。随后,我们着手鉴定该酶药物靶点的结构、功能和稳定性。我们的研究表明,sp-DHDPS折叠且具有活性,k(cat)=22 s(-1),K(M)(PYR)=2.55±0.05 mM,K(M)(ASA)=0.044±0.003 mM。热变性实验表明,sp-DHDPS的表观解链温度(T(M)(app))为72°C,显著高于大肠杆菌DHDPS(Ec-DHDPS)(T(M)(app)=59°C)。沉降研究表明,sp-DHDPS以二聚体-四聚体平衡存在,K(D)(4→2)=1.7 nM,这比其大肠杆菌同源物(K(D)(4→2)=76 nM)紧密得多。为了进一步鉴定该酶的结构并探究其增强的稳定性,我们解析了sp-DHDPS的高分辨率(1.9 Å)晶体结构(PDB ID 3VFL)。该酶在晶体状态下为四聚体,与溶液中的生物物理测量结果一致。尽管sp-DHDPS和Ec-DHDPS的活性位点几乎相同,但肺炎链球菌酶的四聚化界面在组成上有显著差异,与其大肠杆菌对应物相比,具有更大的埋藏表面积(800 Å(2))(500 Å(2))。这个更大的界面面积与我们的溶液研究结果一致,表明sp-DHDPS在热稳定性和热力学稳定性方面比Ec-DHDPS高得多。我们的研究首次描述了肺炎链球菌DHDPS的敲除表型、溶液性质、稳定性和晶体结构,这是一个有前景的抗菌靶点。